T Cell Biomarker Predicts Response to CAR T Cell Therapy – Technology Networks
Technology Networks |
T Cell Biomarker Predicts Response to CAR T Cell Therapy
Technology Networks Penn Medicine researchers may have found the reason why some patients with advanced chronic lymphocytic leukemia (CLL) don't respond to chimeric antigen receptor (CAR) T cell therapy, and the answer is tied to how primed patients' immune systems are … |
